ACUTE RESPIRATORY VIRAL INFECTION
Clinical trials for ACUTE RESPIRATORY VIRAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new ACUTE RESPIRATORY VIRAL INFECTION trials appear
Sign up with your email to follow new studies for ACUTE RESPIRATORY VIRAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New flu pill aims to knock out fever and stuffy nose in record time
Symptom relief Recruiting nowThis study tests a higher-dose version of the antiviral drug Ingavirin (called Ingavirin Forte) in 300 adults with confirmed flu or other viral colds. The goal is to see if it shortens how long symptoms like fever, runny nose, sore throat, cough, and body aches last. Participants…
Matched conditions: ACUTE RESPIRATORY VIRAL INFECTION
Phase: PHASE2 • Sponsor: Valenta Pharm JSC • Aim: Symptom relief
Last updated May 26, 2026 11:48 UTC
-
New drug raphamin aims to shorten Kids' colds in major trial
Symptom relief Recruiting nowThis study tests whether a medicine called Raphamin helps children aged 3 to 12 recover faster from common colds and flu-like illnesses. About 374 children will receive either Raphamin or a placebo, and researchers will track how quickly symptoms like fever and stuffy nose go awa…
Matched conditions: ACUTE RESPIRATORY VIRAL INFECTION
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated May 26, 2026 11:46 UTC